Home

Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation...

Tailwinds' Take: Mustang continues to march towards successfully obtaining approval for their novel drugs. We believe MBIO is deeply discounted relative to the value...

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

Tailwinds' Take: Yay! This long-awaited IND filing is game-changing for Anixa as it marks a significant milestone and brings them to the verge of...

Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP Manufacturing Agreement for...

Tailwinds' Take: planned expansion into Europe is a positive for this program. We continue to be very supportive of MBIO heading into their data...

A Micro Thanksgiving

Thanksgiving is usually a time to gather with friends and family to celebrate life. My favorite holiday of the year, it was always a...

Trading Ideas Heading Towards Year-End

~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...

LEXAGENE PLACES MIQLAB SYSTEM AT THE UNIVERSITY OF PENNSYLVANIA’S SCHOOL OF VETERINARY MEDICINE

Tailwinds' Take: We expect to see continued ramp-up of installations now that manufacturing has been ironed out and product is rolling out to the...

Lantern Pharma Earnings Call Transcript

Panna Sharma: Thank you Marek, and good afternoon to everyone on the call today. Thank you for joining us for our third quarter 2020 conference...

Processa Pharmaceuticas Transcript

Transcript of Processa Pharmaceuticals Business Update November 12, 2020 Participants David Young – Chief Executive Officer Jim Stanker – Chief Financial Officer Sian Bigora – Chief Development Officer Analysts Robin Garner...

LEXAGENE RECEIVES PURCHASE ORDER FROM A MULTINATIONAL BIOTECHNOLOGY COMPANY

Tailwinds' Take: this is exciting news as the LexaGene PCR test is receiving customer approval prior to the official launch. The platform is very...

The Biden Rally

As most of my readers know, I reserve Saturday mornings for writing my weekly newsletter. This week, however, Saturday morning marks the arrival of...

Harrow Health Third Quarter 2020 Letter to Stockholders

Tailwinds' Take: below are the key pieces of Harrow's letter to investors. Harrow has done a great job managing through Covid-19 and the Company...

Pfizer Develops a Vaccine…Implications for Tailwinds

On Monday morning, Pfizer (PFE) announced that they have a very effective vaccine for Covid-19. This, combined with what appears to be a clear...

ParkerVision Files Against Zyxel and Buffalo for Patent Infringement

Tailwinds' Take: PRKR continues to file lawsuits against a number of companies. We expect to start seeing some settlements on these smaller cases in...

Summit Wireless Technologies Gains Momentum and Provides Third Quarter 2020 Update

Tailwinds' Take: momentum continues to build here. Acceleration in 2021 would be huge and push the stock higher. SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (NASDAQ:...

Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for...

Tailwinds' Take: very positive results for a drug that could be equally efficacious and lower cost in a $10B market. A Fortress Bio (FBIO)...

INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for...

Tailwinds' Take: very positive news for a stock that has been awaiting some. We believe that Quellor will be very effective in reducing cytokine...

Moving Week

What do Donald Trump and I have in common? We are both in the process of moving... This week we found out that Joe Biden...

TFFP, INMB, OTRK…Earnings Logjam At Tailwinds

Yesterday afternoon, to my sheer delight, three companies in which I and/or my readers have large holdings all reported earnings at the same time....

INmune Bio, Inc. Announces Third Quarter Results and Provides Business Update

LA JOLLA, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness...

TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--Nov. 5, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...

Become a Tailwinds Member

All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.

For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $250 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.

SIGN ME UP

Receive Our Weekly Newsletter

Every Sunday we recap the market and consolidate the news from our universe. It’s free to subscribe. Just click on the link below.

Newsletter Signup

DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.